Abraham Avigdor

専門分野: Hematologist
35年の経験
話します:
English, Hebrew
オンラインコンサルテーション：利用可能
勤務先: イスラエル, ラマト・ガン, シェバ医療センター
Director of the Institute of Hematology; founder and president of the Israeli Lymphoma Working Group; author of 130+ scientific publications.
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Abraham Avigdorとのオンラインコンサルテーション

便利で簡単

100%安全で機密

$650

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Dr. Abraham Avigdor, MD

Director, Institute of Hematology & Co-Director, Hematology and Bone Marrow Transplantation Division – Sheba Medical Center

Global Leader in Lymphoma, CAR-T Therapy & Advanced Hemato-Oncology

Dr. Abraham Avigdor is a highly distinguished hemato-oncologist with over 35 years of experience, specializing in the treatment of lymphomas, multiple myeloma, and complex blood cancers.

As Director of the Institute of Hematology at Sheba Medical Center, he leads one of the region’s most advanced programs in bone marrow transplantation and cellular therapies, including CAR-T treatment.

Areas of Expertise

Lymphoma (Primary Focus)
Expert in all types of lymphoma, including Hodgkin and Non-Hodgkin lymphoma
Advanced Hemato-Oncology Treatments
- CAR-T Cell Therapy – pioneer in integrating CAR-T into lymphoma and myeloma treatment
- Bone Marrow Transplantation – both autologous and allogeneic transplants
- Stem Cell Therapies and advanced cellular treatments
Multiple Myeloma
Personalized and innovative treatment strategies for complex cases
Precision Diagnostics
Use of PET/CT imaging as a prognostic tool and integration of biological and immunological therapies

Clinical Leadership & Innovation

Dr. Avigdor is internationally recognized for advancing modern lymphoma care, focusing on:

Integration of immunotherapy and targeted treatments
Development of innovative treatment protocols
Personalized, data-driven patient management

His work has helped shape the use of CAR-T therapy as a standard option in advanced hematologic cancers.

International Research & Collaboration

Dr. Avigdor collaborates with leading global research groups, including:

LYSA (France) – Lymphoma Study Association
European Mantle Cell Lymphoma Network (EMCL)
International PET Study Groups in Lymphoma & Myeloma

He has authored 130+ scientific publications, contributing significantly to advancements in lymphoma treatment and cellular therapies.

Leadership & Academic Roles

Director, Institute of Hematology, Sheba Medical Center
Co-Director, Hematology & Bone Marrow Transplant Division
Founder & President, Israeli Lymphoma Working Group
Former Chairman, Israeli Lymphoma Study Group (2011–2018)
Senior Lecturer, Tel Aviv University
Member, National Hematology Consultation Committee (Health Basket)

Education & Training

MD, Ben-Gurion University of the Negev
Residency in Internal Medicine & Hematology, Sheba Medical Center
Postdoctoral Fellowship in Stem Cell Biology, Weizmann Institute of Science

Awards & Recognition

Knesset Prize for excellence in medical studies
Israeli Ministry of Health Award for outstanding physician performance
Sackler Prize for Research Excellence, Tel Aviv University

Patient-Centered Approach

Dr. Avigdor combines decades of experience, global leadership, and cutting-edge therapies to provide highly personalized care for patients with complex blood cancers.

His approach focuses on:

Access to the most advanced treatments worldwide
Multidisciplinary care and precise diagnosis
Improving survival while maintaining quality of life

A Leading Name in Modern Hemato-Oncology

Through his leadership in CAR-T therapy, bone marrow transplantation, and lymphoma research, Dr. Avigdor offers patients access to one of the most advanced and comprehensive blood cancer programs globally.